A field guide to testosterone care For the questions that matter.
FieldworkTHE TRT FIELD GUIDE
Menu
Medications · 4 MIN READ

AndroGel 1.62% vs compounded testosterone cream: important differences

Editorial research · Clinical review not completed

AndroGel 1.62% and a compounded testosterone cream can both be described as topical testosterone, but that shared description does not make them the same medicine. The finished product, concentration, base, application site, and monitoring instructions can differ. A percentage on the label is not a conversion guide.

This comparison uses the current AndroGel 1.62% prescribing information and FDA compounding guidance checked September 21, 2026. It addresses product differences, not which treatment is right for you. We have not verified that every clinic in our directory offers AndroGel or a particular compounded cream.

THE USEFUL PART, UP FRONT
  • AndroGel 1.62% and compounded cream are not automatically interchangeable.
  • Follow product-specific application and household-contact precautions.
  • Confirm the exact prescription before comparing price or laboratory results.

Approval applies to the specific finished product

AndroGel 1.62% is an FDA-approved testosterone product with a defined formulation and prescribing label. A compounded cream is prepared to meet an individual medical need and is not FDA-approved. FDA approval of testosterone in another product does not transfer to the compounded preparation.

If a clinician proposes compounding, ask why it is needed and which approved options could be considered. Our compounded-versus-approved guide explains the distinction without assuming that every patient should receive the same formulation. The decision requires more than comparing the name of the active ingredient.

Application instructions cannot be borrowed

The AndroGel 1.62% label specifies application to the shoulders and upper arms. It does not authorize application wherever another cream is used. The label also distinguishes this product’s directions from those for AndroGel 1%, which can create confusion even within the same brand family.

Ask the pharmacist to identify the precise product and demonstrate how its packaging measures the prescribed amount. Do not convert between pump actuations, packets, or cream quantities yourself. A change in concentration or base can alter exposure, so an apparently similar topical prescription still requires clear new instructions.

Household contact is part of the routine

AndroGel carries a boxed warning about secondary exposure to testosterone, including effects reported in children. Its instructions include washing hands after application, allowing the gel to dry, covering the treated area, and washing the application site before anticipated skin contact with another person.

The label also specifies a minimum interval before swimming or washing after application and warns about flammability until dry. Ask how the complete directions fit your household and schedule. A compounded cream needs its own written precautions; do not assume a different texture removes the possibility of exposing someone else.

Laboratory timing matters when comparing treatments

The label specifies how clinicians use testosterone measurements to review AndroGel 1.62% treatment. A result drawn at the wrong point relative to application can be difficult to interpret. Ask the treating team for the collection timing applicable to your exact prescription rather than borrowing instructions from an injection program.

Keep the product name, concentration, application schedule, and test date with your records. The total-versus-free testosterone guide explains another reason that isolated numbers need context. Dose changes should be based on clinical review, not a comparison with another person’s laboratory result.

Both routes require a discussion of risks

Topical delivery does not make testosterone free of systemic adverse effects. AndroGel’s label addresses blood-pressure increases, elevated blood counts, clotting concerns, prostate-related assessment, sleep apnea, fertility, and other precautions. It also states that safety and effectiveness for age-related hypogonadism have not been established.

Discuss relevant conditions and other medicines before treatment. If you are considering a switch because of an adverse effect, contact the prescriber rather than stopping, substituting, or changing the amount on your own. Our monitoring guide explains the ongoing care questions.

Compare a confirmed prescription and complete cost

Ask which pharmacy would dispense the medicine, whether an approved generic is an option, and what the actual prescription would cost. A compounded-cream membership and a pharmacy price for an approved gel may include different services. Neither should be used as a stand-in for the complete cost of care.

A helpful decision includes product identity, clinical suitability, practical handling, monitoring, and a clear budget. If you want to discuss another non-injection route, the Natesto guide covers a nasal formulation with a different daily routine and its own precautions.

Sources & reading notes

Provider pages describe advertised services, not independently verified outcomes. Prices and eligibility may change. Research checked September 21, 2026. Article updated September 21, 2026.

  1. DailyMed: ANDROGEL 1.62% testosterone gel prescribing information
  2. FDA: understanding the risks of compounded drugs
  3. MedlinePlus: testosterone topical precautions
  4. Endocrine Society: testosterone therapy clinical practice guideline
  5. FDA: 2025 testosterone labeling changes and blood pressure warnings
This article is educational and cannot determine whether TRT is appropriate for you. Discuss diagnosis, treatment, and follow-up with a qualified clinician.